HUMAN INTERFERON ENHANCES GUANYLATE CYCLASE ACTIVITYVESELY DL; CANTELL K.1980; BIOCHEM. BIOPHYS. RES. COMMUN.; ISSN 0006-291X; USA; DA. 1980; VOL. 96; NO 2; PP. 574-579; BIBL. 10 REF.Article

CLEARANCE OF HUMAN INTERFERON RABBITS INDUCED TO MAKE RABBIT INTERFERON = ELIMINATION DE L'INTERFERON HUMAIN CHEZ LES LAPINS CHEZ LESQUELS ON INDUIT L'INTERFERONPYHALA L; CANTELL K.1974; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1974; VOL. 146; NO 2; PP. 394-397; BIBL. 9 REF.Article

STABILITY OF HUMAN LEUKOCYTE INTERFERON TOWARDS HEATMOGENSEN KE; CANTELL K.1973; ACTA PATHOL. MICROBIOL. SCAND., B; DANEM.; DA. 1973; VOL. 81; NO 3; PP. 382-383; BIBL. 11REF.Serial Issue

Development of antiviral therapy with alpha interferons : promises, false hopes and accomplishmentsCANTELL, K.Annals of medicine (Helsinki). 1995, Vol 27, Num 1, pp 23-28, issn 0785-3890Article

EFFECT OF GLYCOSYLATION INHIBITORS ON THE PRODUCTION AND PROPERTIES OF HUMAN LEUKOCYTE INTERFERONKOISTINEN V; CANTELL K.1979; VIROLOGY; USA; DA. 1979; VOL. 97; NO 2; PP. 473-476; BIBL. 17 REF.Article

SUBSTITUTION OF MILK FOR SERUM IN THE PRODUCTION OF HUMAN LEUKOCYTE INTERFERONCANTELL K; TOVELL DR.1971; APPL. MICROBIOL.; U.S.A.; DA. 1971; VOL. 22; NO 4; PP. 625-628; BIBL. 7REF.Serial Issue

PREPARATION AND ASSAY OF SENDAI VIRUS = PREPARATION ET DOSAGE DU VIRUS SENDAICANTELL K; HIRVONEN S.1981; METHODS ENZYMOL.; ISSN 0076-6879; USA; DA. 1981; VOL. 78; PP. 299-301; BIBL. 4 REF.Article

NON-SPECIFIC ADSORPTION OF INTERFERON TO IMMOBILIZED SERUM IMMUNOGLOBULINMOGENSEN KE; CANTELL K.1979; J. GEN. VIROL.; GBR; DA. 1979; VOL. 45; NO 1; PP. 170-174; BIBL. 12 REF.Article

LARGE-SCALE PRODUCTION OF HUMAN LEUKOCYTE INTERFERON CONTAINING 10⁸ UNITS PER ML.CANTELL K; HIRVONEN S.1978; J. GEN. VIROL.; G.B.; DA. 1978; VOL. 39; NO 3; PP. 541-543; BIBL. 3 REF.Article

SUCCESSFUL TREATMENT OF DENDRITIC KERATITIS WITH HUMAN LEUKOCYTE INTERFERON. A CONTROLLED CLINICAL STUDY.SUNDMACHER R; NEUMANN HAEFELIN D; CANTELL K et al.1976; ARCH. (ALBRECHT VON GRAEFES) KLIN. EXPER. OPHTHALMOL.; DTSCH.; DA. 1976; VOL. 201; NO 1; PP. 39-45; BIBL. 10 REF.Article

THE VALUE OF EXOGENOUS INTERFERON IN ADENOVIRUS KERATOCONJUNCTIVITISSUNDMACHER R; WIGAND R; CANTELL K et al.1982; GRAEFE'S ARCH. CLIN. EXP. OPHTHALMOL.; DEU; DA. 1982; VOL. 218; NO 3; PP. 139-140; ABS. GER; BIBL. 8 REF.Article

VIRUS INFECTIONS AND RECURRENCE OF OSTEOSARCOMA IN PATIENTS RECEIVING HUMAN LEUKOCYTE INTERFERONINGIMARSSON S; CANTELL K; STRANDER H et al.1980; INT. J. CANCER; ISSN 0020-7136; CHE; DA. 1980; VOL. 26; NO 4; PP. 395-399; BIBL. 31 REF.Article

REGULATORY EFFECT OF INTERFERON ON T CELLS IN VITRO.HERON I; BERG K; CANTELL K et al.1976; J. IMMUNOL.; U.S.A.; DA. 1976; VOL. 117; NO 4; PP. 1370-1373; BIBL. 14 REF.Article

RAISING ANTIBODIES TO HUMAN LEUKOCYTE INTERFERONMOGENSEN KE; PYHAELAE L; CANTELL K et al.1975; ACTA PATHOL. MICROBIOL. SCAND., B; DANEM.; DA. 1975; VOL. 83; NO 5; PP. 443-450; BIBL. 18 REF.Article

SENSITIVITY OF THE EPSTEIN-BARR VIRUS TRANSFORMED HUMAN LYMPHOID CELL LINES TO INTERFERONADAMS A; STRANDER H; CANTELL K et al.1975; J. GEN. VIROL.; G.B.; DA. 1975; VOL. 28; NO 2; PP. 207-217; BIBL. 1 P. 1/2Article

HIGHLY PURIFIED LEUCOCYTE INTERFERONS FOR RENAL TRANSPLANT RECIPIENTSWEIMAR W; MOGENSEN KE; CANTELL K et al.1982; BIOMEDICINE; ISSN 0300-0893; FRA; DA. 1982; VOL. 36; NO 2; PP. 94-97; ABS. FRE; BIBL. 13 REF.Article

HUMAN NATURAL KILLER CELL ACTIVITY IS AUGMENTED BY INTERFERON VIA RECRUITMENT OF "PRE-NK" CELLSSAKSELA E; TIMONEN T; CANTELL K et al.1979; SCAND. J. IMMUNOL.; NOR; DA. 1979; VOL. 10; NO 3; PP. 257-266; BIBL. 31 REF.Article

LE TRAITEMENT INTERFERON POUR LES KERATITES HERPETIQUES SIMPLEXDE KONING EW; VAN BIJSTERVELD OP; CANTELL K et al.1982; BULLETIN DES SOCIETES D'OPHTALMOLOGIE DE FRANCE; ISSN 0081-1270; FRA; DA. 1982; VOL. 82; NO 6-7; PP. 949Article

FAILURE OF INTERFERON TO MODIFY CREUTZFELDT-JAKOB DISEASEKOVANEN J; HALTIA M; CANTELL K et al.1980; BRIT. MED. J.; GBR; DA. 1980; NO 6218; PP. 902; BIBL. 5 REF.Article

LARGE SCALE PRODUCTION AND PROPERTIES OF HUMAN LEUKOCYTE INTERFERON USED IN CLINICAL TRIALSKAUPPINEN HL; MYLLYLA G; CANTELL K et al.1978; ADV. EXPER. MED. BIOL.; USA; DA. 1978; VOL. 110; PP. 1-13; BIBL. 8 REF.Article

INTERFERON CROSSES BLOOD-CEREBROSPINAL FLUID BARRIER IN MONKEYS.HABIF DV; LIPTON R; CANTELL K et al.1975; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1975; VOL. 149; NO 1; PP. 287-289; BIBL. 12 REF.Article

LA COMBINAISON INTERFERON-TRIFLUOROTHYMIDINE DANS LE TRAITEMENT DES KERATITES HERPETIQUESDE KONING EWJ; VAN BUSTERVELD OP; CANTELL K et al.1983; BULLETINS ET MEMOIRES DE LA SOCIETE FRANCAISE D'OPHTALMOLOGIE; ISSN 0081-1092; FRA; DA. 1983; VOL. 94; PP. 130-132; BIBL. 7 REF.Article

ALPHA INTERFERON ADMINISTRATION TO INFANTS WITH CONGENITAL RUBELLAARVIN AM; SCHMIDT NJ; CANTELL K et al.1982; ANTIMICROB. AGENTS CHEMOTHER.; ISSN 0066-4804; USA; DA. 1982; VOL. 21; NO 2; PP. 259-261; BIBL. 10 REF.Article

VIRAL ANTIBODIES IN MOTHERS OF DEFECTIVE CHILDREN = ANTICORPS VIRAUX CHEZ LES MERES D'ENFANTS ANORMAUXLAPINLEIMU K; KOSKIMIES O; CANTELL K et al.1972; TERATOLOGY; U.S.A.; DA. 1972; VOL. 5; NO 3; PP. 345-351; BIBL. 20REF.Serial Issue

INTERFERON AND SERUM THYROID HORMONES = L'INTERFERON ET LES HORMONES THYROIDIENNES SERIQUESORAVA M; CANTELL K; KAUPPILA A et al.1983; INTERNATIONAL JOURNAL OF CANCER; ISSN 0020-7136; CHE; DA. 1983; VOL. 31; NO 5; PP. 671-672; ABS. ENG; BIBL. 4 REF.; GRAPHArticle